High-dose intravenous immunoglobulin (IVIG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for High-dose intravenous immunoglobulin (IVIG), covering 2022-10-07 to 2022-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) [Phase 2]